TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/08/2026
Back to search
Official data from USPTO
HUMAN PHOTOSYNTHESIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HUMAN PHOTOSYNTHESIS
ST13
US500000077748311Class
5
Filing
77748311
Registration
4478337
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
95
Latest update
06/10/2026
Trademark type
Word
Nice classes
5
Filing date
05/30/2009
Registration date
02/04/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2023
Last transaction
06/10/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
06/11/2005
First use in commerce
01/25/2013
Drawing code
4
Owner type
03
Owner location
Aguascalientes, MX
Examiner
CHANG, KATHERINE S
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Formulas Magistrales SA de CV
Representatives
Holly M. Ford Lewis Panitch Schwarze Belisario & Nadel LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Homeopathic pharmaceuticals for smoking cessation; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with nicotine for smoking cessation; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; for the treatment of inflammatory disorders; for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti- infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Pharmaceutical preparations for the prevention of arthritisAlzheimer's diseaseParkinson's disease; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparationsantidepressants; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticalsinducers of erections; Pharmaceuticalspsychotropics; Plant extracts for medicalveterinary and pharmaceutical purposes; Therapeutic pharmaceutical for smoking cessation
Publications
History of USPTO decisions and trademark events.
95 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/08/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/08/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/08/2026
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/29/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/29/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/29/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/29/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/29/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/29/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/29/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/05/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/02/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/02/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/02/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/21/2023
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/21/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/21/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/21/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
04/25/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/04/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/21/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/21/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/21/2020
E815
TEAS SECTION 8 & 15 RECEIVED
12/20/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/04/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/10/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/10/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/28/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/28/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/01/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/31/2013
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/20/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2013
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/19/2013
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/09/2013
GNFR
FINAL REFUSAL E-MAILED
07/09/2013
CNFR
SU - FINAL REFUSAL - WRITTEN
07/09/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/02/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/02/2013
GNRT
NON-FINAL ACTION E-MAILED
07/02/2013
CNRT
SU - NON-FINAL ACTION - WRITTEN
07/02/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/26/2013
EISU
TEAS STATEMENT OF USE RECEIVED
06/24/2013
IUAF
USE AMENDMENT FILED
06/22/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/10/2013
EX5G
SOU EXTENSION 5 GRANTED
01/09/2013
PAPER RECEIVED
12/31/2012
EXT5
SOU EXTENSION 5 FILED
12/22/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/21/2012
EX4G
SOU EXTENSION 4 GRANTED
06/20/2012
EXT4
SOU EXTENSION 4 FILED
06/19/2012
EEXT
SOU TEAS EXTENSION RECEIVED
06/19/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/24/2012
UNDN
UNDELIVERABLE MAIL - NO ACTION TAKEN
02/01/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
01/04/2012
EX3G
SOU EXTENSION 3 GRANTED
01/03/2012
EXT3
SOU EXTENSION 3 FILED
12/22/2011
EEXT
SOU TEAS EXTENSION RECEIVED
12/22/2011
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
06/25/2011
EX2G
SOU EXTENSION 2 GRANTED
06/24/2011
EXT2
SOU EXTENSION 2 FILED
06/22/2011
EEXT
SOU TEAS EXTENSION RECEIVED
06/22/2011
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
01/22/2011
EX1G
SOU EXTENSION 1 GRANTED
01/21/2011
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/21/2011
EXT1
SOU EXTENSION 1 FILED
12/22/2010
EEXT
SOU TEAS EXTENSION RECEIVED
12/22/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
06/22/2010
PUBO
PUBLISHED FOR OPPOSITION
04/27/2010
NPUB
NOTICE OF PUBLICATION
04/07/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/22/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/16/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/16/2010
ALIE
ASSIGNED TO LIE
03/16/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/03/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/03/2009
GNRT
NON-FINAL ACTION E-MAILED
09/03/2009
CNRT
NON-FINAL ACTION WRITTEN
09/03/2009
DOCK
ASSIGNED TO EXAMINER
08/31/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2009
NWAP
NEW APPLICATION ENTERED
06/03/2009
Continuous trademark protection
Get notified about every new filing that threatens HUMAN PHOTOSYNTHESIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.